JPH07505629A - パスツレラ・ヘモリティカ・タイプa−1・バクテリン−トキソイドワクチン - Google Patents
パスツレラ・ヘモリティカ・タイプa−1・バクテリン−トキソイドワクチンInfo
- Publication number
- JPH07505629A JPH07505629A JP5517608A JP51760893A JPH07505629A JP H07505629 A JPH07505629 A JP H07505629A JP 5517608 A JP5517608 A JP 5517608A JP 51760893 A JP51760893 A JP 51760893A JP H07505629 A JPH07505629 A JP H07505629A
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- haemolytica
- type
- pasteurella
- inactivated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Detergent Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
Claims (24)
- 1.治療上有効量のパスツレラ・ヘモリティカ・タイプA−1(Pasteur ellahaemolytica Type A−1)・ロイコトキソイド、莢 膜抗原、可溶性抗原および不活性化細胞からなり、1回の接種でウシ種における パスツレラ・ヘモリティカ・タイプA−1に対する免疫性を誘導することのでき るバクテリン−トキソイドワクチン。
- 2.ロイコトキソイド、莢膜抗原、可溶性抗原および不活性化パスツレラ・ヘモ リティカがATCC55318株由来である請求項1記載のワクチン。
- 3.さらに治療上有効量の1種またはそれ以上のウシの呼吸器疾患の病因となる 付加的な抗原からなる請求項1記載のワクチン。
- 4.ワクチンが凍結乾燥されており、使用前に少なくとも1種のアジュバントと ともに再水和される請求項1記載のワクチン。
- 5.さらに2種のアジュバントからなる請求項4記載のワクチン。
- 6.アジュバントが12%(v/v)水酸化アルミニウムゲルおよびアムフィジ ェン(Amphigen(R))からなる請求項5記載のワクチン。
- 7.免疫性の持続期間が約4カ月である請求項1記載のワクチン。
- 8.治療上有効量のパスツレラ・ヘモリティカ・タイプA−1・ロイコトキソイ ド、莢膜抗原、可溶性抗原および不活性化細胞からなり、1回の接種でウシ種に おけるパスツレラ・ヘモリティカ・タイプA−1に対する免疫性を誘導すること のできるバクテリン−トキソイドワクチンの製造方法であって、パスツレラ・ヘ モリティカ・タイプA−1を後期対数増殖期に至るに十分な時間培養し;ピー・ ヘモリティカ培養物を不活性化し;ロイコトキソイド、莢膜抗原、可溶性抗原お よび不活性化ピー・ヘモリティカ細胞からなる培養液を得ることからなる製造方 法。
- 9.ピー・ヘモリティカがATCC55318株である請求項8記載の方法。
- 10.該ピー・ヘモリティカが後期対数増殖期に至るまでの該十分な時間が約2 .5ないし6時間である請求項8記載の方法。
- 11.ピー・ヘモリティカ培養がホルマリンで不活性化される請求項8記載の方 法。
- 12.遠心分離により上清を得る請求項8記載の方法。
- 13.蛋白を増強した細胞培養培地でビー・ヘモリティカを培養する請求項13 記載の方法。
- 14.細胞培養培地がRPMI−1640および約3%の子ウシ・血清、約1% のトリプトースならびに0.1%のツイン(Tween)80からなる請求項1 3記載の方法。
- 15.請求項8記載の方法により製造されるワクチン。
- 16.ワクチンが凍結乾燥されており、使用前に少なくとも1種のアジュバント とともに再水和される請求項15記載のワクチン。
- 17.さらに2種のアジュバントからなる請求項16記載のワクチン。
- 18.ワクチンがアジュバント12%(v/v)水酸化アルミニウムゲルおよび アンフィジェン(R)からなる請求項17記載のワクチン。
- 19.該動物に請求項1または15記載のバクテリン−トキソイドワクチンを投 与することからなるウシ科動物の予防接種法。
- 20.該投与が筋肉内または皮下注射である請求項19記載の方法。
- 21.ワクチンが凍結乾燥形態であり、使用前に少なくとも1種のアジュバント とともに復元される請求項19記載の方法。
- 22.ワクチンが2種のアジュバントからなる請求項21記載の方法。
- 23.アジュバントが12%(v/v)水酸化アルミニウムゲルおよびアンフィ ジェン(R)である請求項19記載の方法。
- 24.ATCC55318とすべて同じ性質を有するパスツレラ・ヘモリティカ の生物学的に純粋な培養。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US860,377 | 1986-05-06 | ||
US86037792A | 1992-03-30 | 1992-03-30 | |
US86993492A | 1992-04-16 | 1992-04-16 | |
US87814692A | 1992-05-04 | 1992-05-04 | |
US869,934 | 1992-05-04 | ||
US878,146 | 1992-05-04 | ||
PCT/US1993/002930 WO1993019779A1 (en) | 1992-03-30 | 1993-03-30 | Pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07505629A true JPH07505629A (ja) | 1995-06-22 |
JP2776982B2 JP2776982B2 (ja) | 1998-07-16 |
Family
ID=27420408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5517608A Expired - Lifetime JP2776982B2 (ja) | 1992-03-30 | 1993-03-30 | パスツレラ・ヘモリティカ・タイプa−1・バクテリン−トキソイドワクチン |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0636030B1 (ja) |
JP (1) | JP2776982B2 (ja) |
AT (1) | ATE258445T1 (ja) |
AU (2) | AU3970093A (ja) |
BR (1) | BR9306187A (ja) |
CA (1) | CA2133108C (ja) |
DE (1) | DE69333402T2 (ja) |
DK (1) | DK0636030T3 (ja) |
ES (1) | ES2211866T3 (ja) |
MX (1) | MX9301736A (ja) |
PT (1) | PT636030E (ja) |
WO (1) | WO1993019779A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5855894A (en) * | 1992-03-30 | 1999-01-05 | Pfizer Inc. | Pasteurella haemolytica type A-1 bacterin-toxoid vaccine |
EA011578B1 (ru) | 2002-08-26 | 2009-04-28 | Пфайзер Продактс Инк. | Иммуногенная композиция для защиты крупного рогатого скота от инфекций респираторной и репродуктивной систем и ее применение |
PL3166634T3 (pl) | 2014-07-11 | 2021-12-27 | Zoetis Services Llc | Nowe kompozycje szczepionek przeciwko wirusowi biegunki epidemicznej świń |
EP3261668A4 (en) | 2015-02-27 | 2018-10-24 | Iowa State University Research Foundation, Inc. | Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom |
CN107569681B (zh) * | 2017-08-30 | 2022-02-15 | 中国农业科学院哈尔滨兽医研究所 | 一种牛多杀性巴氏杆菌病二价灭活疫苗及其制备方法 |
TW202214294A (zh) * | 2020-09-30 | 2022-04-16 | 美商碩騰服務公司 | 具有hyaC及nanP缺失之新穎多殺性巴斯德氏菌株及疫苗 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS496118A (ja) * | 1972-03-29 | 1974-01-19 | ||
WO1980000412A1 (en) * | 1978-08-24 | 1980-03-20 | N Gilmour | Pasteurellosis vaccines |
WO1991015237A1 (en) * | 1990-04-05 | 1991-10-17 | University Of Saskatchewan | Compositions and treatments for pneumonia in animals |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4746613A (en) * | 1984-03-02 | 1988-05-24 | Wichmann Robert W | Poultry diseases bacterin preparation |
US5084269A (en) * | 1986-11-06 | 1992-01-28 | Kullenberg Fred W | Adjuvant for dose treatment with antigens |
US5114849A (en) * | 1990-10-26 | 1992-05-19 | Weyerhaeuser Company | Protectants for microbial fermentation |
-
1993
- 1993-03-26 MX MX9301736A patent/MX9301736A/es unknown
- 1993-03-30 JP JP5517608A patent/JP2776982B2/ja not_active Expired - Lifetime
- 1993-03-30 EP EP93909199A patent/EP0636030B1/en not_active Expired - Lifetime
- 1993-03-30 DK DK93909199T patent/DK0636030T3/da active
- 1993-03-30 DE DE69333402T patent/DE69333402T2/de not_active Expired - Lifetime
- 1993-03-30 ES ES93909199T patent/ES2211866T3/es not_active Expired - Lifetime
- 1993-03-30 AU AU39700/93A patent/AU3970093A/en not_active Abandoned
- 1993-03-30 PT PT93909199T patent/PT636030E/pt unknown
- 1993-03-30 WO PCT/US1993/002930 patent/WO1993019779A1/en active IP Right Grant
- 1993-03-30 AT AT93909199T patent/ATE258445T1/de active
- 1993-03-30 BR BR9306187A patent/BR9306187A/pt not_active Application Discontinuation
- 1993-03-30 CA CA002133108A patent/CA2133108C/en not_active Expired - Lifetime
-
1996
- 1996-08-29 AU AU64355/96A patent/AU707841B2/en not_active Expired
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS496118A (ja) * | 1972-03-29 | 1974-01-19 | ||
WO1980000412A1 (en) * | 1978-08-24 | 1980-03-20 | N Gilmour | Pasteurellosis vaccines |
WO1991015237A1 (en) * | 1990-04-05 | 1991-10-17 | University Of Saskatchewan | Compositions and treatments for pneumonia in animals |
Also Published As
Publication number | Publication date |
---|---|
DE69333402T2 (de) | 2004-12-09 |
DK0636030T3 (da) | 2004-04-05 |
EP0636030A4 (en) | 1996-02-07 |
EP0636030B1 (en) | 2004-01-28 |
DE69333402D1 (en) | 2004-03-04 |
PT636030E (pt) | 2004-05-31 |
BR9306187A (pt) | 1997-10-07 |
ATE258445T1 (de) | 2004-02-15 |
EP0636030A1 (en) | 1995-02-01 |
AU6435596A (en) | 1996-11-07 |
CA2133108C (en) | 2005-01-25 |
CA2133108A1 (en) | 1993-10-14 |
JP2776982B2 (ja) | 1998-07-16 |
AU707841B2 (en) | 1999-07-22 |
ES2211866T3 (es) | 2004-07-16 |
WO1993019779A1 (en) | 1993-10-14 |
AU3970093A (en) | 1993-11-08 |
MX9301736A (es) | 1994-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0453024B1 (en) | Actinobacillus pleuropneumoniae subunit vaccine | |
BR112020015696A2 (pt) | Composição de conjugado polissacarídeo-proteína pneumocócico multivalente | |
JP2005515162A (ja) | マイコプラズマ・ハイオニューモニエ(Mycoplasmahyopneumoniae)を用いた単回ワクチン接種 | |
BRPI0720667A2 (pt) | Métodos de administração de vacina | |
US6342231B1 (en) | Haemophilus parasuis vaccine and diagnostic | |
TW494103B (en) | Vaccine against Streptococcus suis infection | |
AU2006231916A1 (en) | Formulations and process for production of Bordetella bronchiseptica p68 antigen and vaccines | |
US5855894A (en) | Pasteurella haemolytica type A-1 bacterin-toxoid vaccine | |
JP3178720B2 (ja) | パスツレラ・ムルトシダのトキソイドワクチン | |
JPH07505629A (ja) | パスツレラ・ヘモリティカ・タイプa−1・バクテリン−トキソイドワクチン | |
Akkoyunlu et al. | The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate | |
Chima et al. | Immunoprophylaxis of experimental Mycoplasma bovis arthritis in calves. Protective efficacy of live organisms and formalinized vaccines | |
WO1993010815A1 (en) | Non-capsulated mutants of bacteria useful as vaccines | |
Donachie | Vaccine development against Pasteurella haemolytica infections in sheep | |
BR112018002919B1 (pt) | Composição imunogênica eficaz compreendendo uma cepa de mycoplasma bovis e usos da mesma para prevenção de doenças causadas por mycoplasma bovis | |
EP4117721A1 (en) | A vaccine for protection against streptococcus suis serotype 9, sequence type 16 | |
Kumar et al. | Immune response and viscosity of haemorrhagic septicaemia oil adjuvant vaccine at different water-oil proportion | |
AU662116B2 (en) | Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines | |
JPH08187093A (ja) | パスツレラの抗原の製造方法 | |
CA2086258C (en) | Pasteurella multocida toxoid vaccines | |
JP2006506615A (ja) | ワクチンのためのマーカー抗原として、およびAmphigenと共同的なアジュバントしてのrmLTの使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S201 | Request for registration of exclusive licence |
Free format text: JAPANESE INTERMEDIATE CODE: R314201 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080501 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090501 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090501 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100501 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110501 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110501 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120501 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130501 Year of fee payment: 15 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130501 Year of fee payment: 15 |
|
R153 | Grant of patent term extension |
Free format text: JAPANESE INTERMEDIATE CODE: R153 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130501 Year of fee payment: 15 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160501 Year of fee payment: 18 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
EXPY | Cancellation because of completion of term |